Pomerantz, Mark
Dana-Farber Cancer Institute
9 papers on CoChatORCID 0000-0003-4914-1157
Most cited papers
- Verified
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
Pomerantz, M. M., Ahmadiyeh, N., Jia, L., Herman, P., Verzi, M. P., Doddapaneni, H., Beckwith, C. A., Chan, J. A., Hills, A., Davis, M., et al. (2009) · Nature Genetics
Genetic Associations and EpidemiologyGenomics and Chromatin Dynamics
Cited by 663
- Verified
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Pomerantz, M. M., Li, F., Takeda, D. Y., Lenci, R., Chonkar, A., Chabot, M., Cejas, P., Vazquez, F., Cook, J., Shivdasani, R. A., et al. (2015) · Nature Genetics
Prostate Cancer Treatment and ResearchChromatin Remodeling and Cancer
Cited by 470
- Verified
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer
Takeda, D. Y., Spisák, S., Seo, J.-H., Bell, C., O’Connor, E., Korthauer, K., Ribli, D., Csabai, I., Solymosi, N., Szállási, Z., et al. (2018) · Cell
Prostate Cancer Treatment and ResearchChromatin Remodeling and Cancer
Cited by 317
- Verified
Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer
Guo, H., Ahmed, M., Zhang, F., Yao, C. Q., Li, S., Liang, Y., Hua, J., Soares, F., Sun, Y., Langstein, J., et al. (2016) · Nature Genetics
Cancer-related molecular mechanisms researchProstate Cancer Treatment and Research
Cited by 226
- Verified
SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Yang, M., Xie, W., Mostaghel, E., Nakabayashi, M., Werner, L., Sun, T., Pomerantz, M., Freedman, M., Ross, R., Regan, M., et al. (2011) · Journal of Clinical Oncology
Prostate Cancer Treatment and ResearchPharmacogenetics and Drug Metabolism
Cited by 159
- Verified
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
Mazzu, Y. Z., Armenia, J., Chakraborty, G., Yoshikawa, Y., Coggins, S. A., Nandakumar, S., Gerke, T. A., Pomerantz, M. M., Qiu, X., Zhao, H., et al. (2019) · Clinical Cancer Research
Prostate Cancer Treatment and ResearchDNA Repair Mechanisms
Cited by 156
- Verified
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
Gusev, A., Shi, H., Kichaev, G., Pomerantz, M., Li, F., Long, H. W., Ingles, S. A., Kittles, R. A., Strom, S. S., Rybicki, B. A., et al. (2016) · Nature Communications
Genetic Associations and EpidemiologyProstate Cancer Treatment and Research
Cited by 51
- Verified
Implementation to optimization: a tailored, data-driven approach to improve provider efficiency and confidence in use of the electronic medical record
Kadish, S. S., Mayer, E. L., Jackman, D. M., Pomerantz, M., Brady, L., Dimitriadis, A., Cleveland, J. L. F., & Wagner, A. J. (2018) · Journal of Oncology Practice
Electronic Health Records SystemsNursing Diagnosis and Documentation
Cited by 27
- Verified
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
Mitchell, J., Camacho, N., Shea, P., Stopsack, K. H., Joseph, V., Burren, O. S., Dhindsa, R. S., Nag, A., Berchuck, J. E., O’Neill, A., et al. (2025) · Nature Communications
BRCA gene mutations in cancerProstate Cancer Treatment and Research
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free